NYSE:VAPO Vapotherm (VAPO) Stock Price, News & Analysis → WARNING about the death of the U.S. dollar… (From Colonial Metals) (Ad) Free VAPO Stock Alerts $0.86 0.00 (0.00%) (As of 05/24/2024 ET) Add Compare Share Share Today's Range$0.86▼$0.8650-Day Range$0.80▼$1.6052-Week Range$0.75▼$7.44Volume23,594 shsAverage Volume16,102 shsMarket Capitalization$5.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Vapotherm alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Vapotherm Stock (NYSE:VAPO)Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.Read More VAPO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VAPO Stock News HeadlinesMay 22, 2024 | americanbankingnews.comReviewing Vapotherm (NYSE:VAPO) and Microbot Medical (NASDAQ:MBOT)May 11, 2024 | finanznachrichten.deVapotherm, Inc.: Vapotherm Reports First Quarter 2024 Financial ResultsMay 9, 2024 | prnewswire.comVapotherm Reports First Quarter 2024 Financial ResultsMay 1, 2024 | finance.yahoo.comVapotherm, Inc. (VAPO)March 20, 2024 | msn.comVapotherm to debut home ventilator to improve patient careMarch 20, 2024 | finance.yahoo.comOnymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)March 15, 2024 | finance.yahoo.comVapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADEMarch 6, 2024 | prnewswire.comDr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patient comfortFebruary 29, 2024 | prnewswire.comVapotherm's HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America's Largest Health Care MarketFebruary 23, 2024 | finanznachrichten.deVapotherm, Inc.: Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsFebruary 22, 2024 | chron.comVapotherm: Q4 Earnings SnapshotFebruary 22, 2024 | prnewswire.comVapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsDecember 15, 2023 | financialpost.comOTC Markets Group Welcomes Vapotherm, Inc. to OTCQXDecember 14, 2023 | finance.yahoo.comNYSE to Commence Delisting Proceedings Against Vapotherm, Inc. (VAPO)December 14, 2023 | marketwatch.comVapotherm Shares Suspended on NYSE, Company Previously Announced Voluntary Delisting PlanDecember 11, 2023 | marketwatch.comVapotherm Shares Decline 22% on Voluntary Delisting Grom NYSEDecember 11, 2023 | msn.comVapotherm slips on announcing voluntary delisting from NYSE to OTCQX MarketplaceDecember 11, 2023 | finance.yahoo.comVapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQXNovember 28, 2023 | finance.yahoo.comVapotherm Educates over 8,000 Clinicians in Respiratory Care MonthNovember 10, 2023 | finance.yahoo.comVapotherm, Inc. (NYSE:VAPO) Q3 2023 Earnings Call TranscriptNovember 8, 2023 | msn.comVapotherm GAAP EPS of -$2.38 misses by $0.18, revenue of $15.2M misses by $1.52MNovember 8, 2023 | finance.yahoo.comVapotherm Reports Third Quarter 2023 Financial ResultsNovember 8, 2023 | uk.finance.yahoo.comVapotherm, Inc. (VAPO) stock price, news, quote & history – Yahoo FinanceNovember 7, 2023 | benzinga.comEarnings Outlook For VapothermNovember 1, 2023 | finance.yahoo.comVapotherm To Report Third Quarter 2023 Financial ResultsSee More Headlines Receive VAPO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vapotherm and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today5/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:VAPO CUSIPN/A CIK1253176 Webwww.vapotherm.com Phone(866) 410-9986FaxN/AEmployees182Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($8.61) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-58,190,000.00 Net Margins-78.40% Pretax Margin-78.22% Return on EquityN/A Return on Assets-67.68% Debt Debt-to-Equity RatioN/A Current Ratio0.30 Quick Ratio0.13 Sales & Book Value Annual Sales$68.67 million Price / Sales0.08 Cash FlowN/A Price / Cash FlowN/A Book Value($11.02) per share Price / Book-0.08Miscellaneous Outstanding Shares6,220,000Free Float5,233,000Market Cap$5.35 million OptionableNo Data Beta-1.05 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Joseph F. Army CPA (Age 60)CEO, President & Director Comp: $776.25kMr. John Landry (Age 51)Senior VP, CFO & Treasurer Comp: $552.05kMr. Brian Lawrence (Age 54)Senior VP & CTO Comp: $551.82kMr. William NilandFounderMs. Dorota Mckay (Age 41)VP, Controller & Chief Accounting Officer Mr. Anthony Ten HaagenVice President of Legal & ComplianceMr. James A. Lightman (Age 66)Senior VP, General Counsel & Secretary Ms. Lindsay Becker (Age 39)Vice President of Human Resources Dr. Jessica Whittle M.D.Ph.D., Chief Medical Officer & VP of Clinical ResearchMore ExecutivesKey CompetitorsBIOLASENASDAQ:BIOLXylo TechnologiesNASDAQ:MDGSIntelligent Bio SolutionsNASDAQ:INBSReShape LifesciencesNASDAQ:RSLSKiromic BioPharmaNASDAQ:KRBPView All CompetitorsInsidersJoseph ArmyBought 21,987 shares on 9/7/2023Total: $72,776.97 ($3.31/share)Anthony L ArnerichBought 5,000 shares on 8/30/2023Total: $14,500.00 ($2.90/share)Joseph ArmyBought 14,907 shares on 8/22/2023Total: $59,329.86 ($3.98/share)Joseph ArmyBought 7,489 shares on 8/18/2023Total: $22,991.23 ($3.07/share)Joseph ArmyBought 2,742 shares on 8/14/2023Total: $8,774.40 ($3.20/share)View All Insider Transactions VAPO Stock Analysis - Frequently Asked Questions How have VAPO shares performed in 2024? Vapotherm's stock was trading at $1.00 on January 1st, 2024. Since then, VAPO stock has decreased by 14.0% and is now trading at $0.86. View the best growth stocks for 2024 here. How were Vapotherm's earnings last quarter? Vapotherm, Inc. (NYSE:VAPO) announced its earnings results on Thursday, May, 9th. The company reported ($2.31) earnings per share for the quarter. The business had revenue of $19.13 million for the quarter. When did Vapotherm's stock split? Vapotherm's stock reverse split on the morning of Friday, August 18th 2023. The 1-8 reverse split was announced on Friday, August 18th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. What is Joe Army's approval rating as Vapotherm's CEO? 65 employees have rated Vapotherm Chief Executive Officer Joe Army on Glassdoor.com. Joe Army has an approval rating of 93% among the company's employees. This puts Joe Army in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Vapotherm own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Micron Technology (MU), Block (SQ), Taiwan Semiconductor Manufacturing (TSM), Synaptics (SYNA), VBI Vaccines (VBIV) and When did Vapotherm IPO? Vapotherm (VAPO) raised $60 million in an initial public offering on Wednesday, November 14th 2018. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. How do I buy shares of Vapotherm? Shares of VAPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:VAPO) was last updated on 5/26/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaWARNING about the death of the U.S. dollar…Colonial Metals$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsBiden replacement revealed?Paradigm PressNew Options need New Trading StrategiesNetpicksWrite this ticker symbol down…StocksToTradeThe only AI company to buyPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vapotherm, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.